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Synopsis 
 
As hypoxic tumours in the head-and-neck are more resistant to radiation therapy, there is a pressing clinical need to 
measure tumour oxygenation non-invasively. Since deoxyhemoglobin in the blood, which indicates hypoxia, is 
paramagnetic, QSM is a candidate technique. Here, we tested QSM’s repeatability in various head-and-neck regions in ten 
healthy volunteers to investigate the feasibility of detecting the susceptibility difference expected to result from hypoxia. We 
found low minimum detectable effect sizes in the lymph nodes (0.12 ppm), submandibular glands (0.08 ppm), and parotid 
glands (0.04 ppm). This high QSM repeatability paves the way for clinical studies. 
 
Purpose  
 
Tumour hypoxia is associated with adverse prognosis after radiotherapy (RT) in head-and-neck cancer1. Therefore, there 
is a pressing clinical need to measure tumour oxygenation and identify hypoxic sites to improve RT treatment. Blood 
deoxyhemoglobin, which increases in hypoxia2, is paramagnetic3 having higher susceptibility than surrounding tissues. 
QSM which calculates tissue magnetic susceptibility from MRI phase images4-6 is a non-invasive method that could be 
useful to measure tissue oxygenation. Here we measured the repeatability of a QSM protocol optimised for the head-and-
neck to determine whether QSM is stable enough to detect hypoxic sites in this region. 
 
Methods 
 
Multi-echo head-and-neck images were acquired in 10 healthy volunteers at 3T (Achieva, Philips Healthcare, NL) using a 
16-channel head-and-neck RF coil and an optimised 3D gradient-echo sequence7,8 (Figure 1a). All volunteers were scanned 
3 times per session at two sessions a week apart to investigate both intrasession and intersession repeatability. Head-and-
neck tissue masks were generated by thresholding the inverse noise map9-10. An optimised QSM pipeline was applied: 1. 
Non-linear field fitting11, 2. Laplacian phase unwrapping12, 3. Projection onto Dipole Fields13, 4. Iterative fitting in image 
space with Tikhonov regularisation10 with regularisation parameter 𝛼 = 0.11  and correction for susceptibility 
underestimation12. 
 
In the first acquired images of each volunteer, brain regions (Figure 1b) were automatically segmented (Figure 2) using 
FSL FIRST14 on the first-echo magnitude images, and neck regions of interest (ROIs) (Figure 1b) were manually delineated 
using ITK- SNAP15-16. Regions were checked by an experienced radiologist (Figure 2). ROIs in the remaining five images 
were delineated using segmentation propagation: the last-echo magnitude image of the first scan was non-rigidly 
registered17-19 to the rest of the last-echo magnitude images and the resulting transformations were used to warp the 
segmented ROIs. All ROIs were checked visually and manually adjusted if necessary (Figure 2). 
 
Mean and median susceptibilities were calculated in all ROIs. The distributions of the susceptibility differences measured 
between scans were used to assess intrasession and intersession repeatability for each ROI. The minimum detectable 
effect size20 (MDE) was calculated for each ROI based on the standard deviation of the corresponding distribution with type 
I and II error rates of 𝛼 = 0.05 and 𝛽 = 0.2 respectively. 
 
Results and Discussion 
 
Figure 3 shows the distributions of intrasession and intersession median susceptibility differences for each ROI. Most of 
the distributions are centered around zero (within 0.02 ppm) except those of the GP (the ROI abbreviations can be found 
in Figure 1b). This could be because the GP has a much higher susceptibility than the surrounding tissue, therefore 
inaccuracies in its segmentation can lead to bigger, systematic errors. The intersession distribution in mN is also 
substantially further off-center than the rest. This could be because intersession co-registration was often inaccurate due 
to the mN’s relatively small size and they were usually surrounded by much more paramagnetic fatty tissue8. lNs were 
larger and were, therefore, segmented with a 2 mm margin on each side mitigating the effects of inaccurate segmentation 
and leading to much higher repeatability (narrower distribution with a center closer to zero). 
 
Brain regions had higher repeatability and, consequently, smaller MDEs (Figure 4) than neck regions. The intrasession 
repeatability was always greater than or equal to the intersession repeatability for each region, especially for the SMg where 
the intersession MDE was double that of the intrasession MDE. This may have been because of positioning, physiological 
or system differences. Susceptibility of the Pg had especially high intrasession and intersession repeatability. All MDEs 
were lower than 0.2 ppm. Results based on the mean susceptibility (not shown) were almost identical in these healthy 
volunteers. 
 
The susceptibility difference between fully oxygenated and fully deoxygenated blood3 is Δ𝜒𝑏𝑙𝑜𝑜𝑑 = 𝐻𝑐𝑡 ⋅ 3.8 𝑝𝑝𝑚, where 𝐻𝑐𝑡 
is the hematocrit. Therefore, the susceptibility difference between hypoxic and normoxic sites can be estimated as 
𝜒ℎ𝑦𝑝𝑜𝑥𝑖𝑐 − 𝜒𝑛𝑜𝑟𝑚𝑜𝑥𝑖𝑐 = 𝑉 ⋅ Δ𝜒𝑏𝑙𝑜𝑜𝑑 , where 𝑉 denotes the vascular density. Substituting 𝐻𝑐𝑡 = 0.4 and 𝑉 =  0.2, which are 
both realistic values for healthy and cancerous tissue21-24, the susceptibility difference is about 0.3 ppm which is substantially 
higher than the measured MDEs. Note that the exact susceptibility difference scales linearly with 𝑉 which was approximated 
to be higher (0.85) by Panek et al.25    
 
 
Conclusions 
 
Susceptibility values measured in healthy lymph nodes, large nodular structures, and the parotid and submandibular glands 
had sufficient repeatability to enable future detection of the estimated susceptibility difference between normoxic and 
hypoxic tissue.  Therefore, QSM could potentially identify hypoxic sites in head-and-neck cancer. Careful delineation of 
ROIs is crucial to avoid inaccuracies, especially if the susceptibility difference between the region and its surroundings is 
high, e.g. for healthy lymph nodes embedded in paramagnetic fatty fascia. 
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Figure 1: MRI acquisition parameters (a) and regions of interest (b).  
 
 
Figure 2: Pipeline for segmenting regions of interest in the brain and the head-and-neck tissues. The example ROIs are 
overlaid on the last-echo magnitude images. 
 
 Figure 3: Box plots of intrasession (top) and intersession (bottom) median susceptibility differences in different ROIs: mN 
– medium-sized lymph nodes (short-axis diameter > 5 mm), lNs – large nodular structures (segmented with a 2 mm 
margin), Pg – parotid gland, SMg – submandibular gland, Thal – thalamus, CN – caudate nucleus, Put – putamen, GP – 
globus pallidus. Standard deviations (SD) of each distribution are displayed at the bottom of both plots. Box plots of the 
mean susceptibility differences were very similar (not shown). 
 
  
Figure 4: Minimum detectable effect sizes (MDE) calculated for each ROI from the intrasession and intersession standard 
deviations of median susceptibility differences. MDEs based on mean susceptibility differences were very similar (not 
shown). 
 
